breast tissue.
-- In a clinical trial of 1,093 women, stereoscopic digital mammography
detected more true lesions than standard digital mammography and
reduced false-positive findings by nearly half.
Note: Copies of RSNA 2007 news releases and electronic images will be
available online at RSNA.org/press07 beginning Monday, Nov. 26.
RSNA is an association of more than 41,000 radiologists, radiation
oncologists, medical physicists and related scientists committed to
excellence in patient care through education and research. The Society is
based in Oak Brook, Ill. (RSNA.org)
Editor's note: The data in these releases may differ from those in the
printed abstract and those actually presented at the meeting, as
researchers continue to update their data right up until the meeting. To
ensure you are using the most up-to-date information, please call the RSNA
Newsroom at 1-312-949-3233.
'/>"/>SOURCE Radiological Society of North America Copyright©2007 PR Newswire. All rights reserved | |
Page: 1 2 3 Related medicine technology :1.
BSGI Posts Higher Sensitivity than Mammography or MRI for the Detection of Ductal Carcinoma In Situ2.
VA National Campaign Takes Aim at Resistant Staph Infections3.
Study Confirms That New Protocol Shortens the Time It Takes to Open Blocked Arteries for Heart Attack Patients4.
Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients5.
Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium6.
Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium7.
Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial8.
EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer9.
Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer10.
FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women11.
New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies